During the past decade, IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla" are "Alzheimer Disease" (4 trials), "Multiple Sclerosis" (4 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Relapsing Multiple Sclerosis" (2 trials). Many other conditions were trialed in "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla" in a lesser frequency.

Most popular intervention types in "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla" are "Drug" (17 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (9 trials), "Gantenerumab" (5 trials), "Placebo" (5 trials), "Fenebrutinib" (2 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla" are 18 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".